학술논문

Circulating tumor DNA is a potential prognostic risk factor of recurrence in patients with hepatocellular carcinoma treated by liver transplantation.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 1 2022, 40 16, pE16196-pE16196, 1p. Supplement: S
Subject
Language
English
ISSN
15277755